Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

Subsidie
€ 4.475.946
2022

Projectdetails

Introduction

Cardiovascular disease (CVD) is still the N1 cause of death worldwide despite the significant efforts of academia and the pharmaceutical industry to understand the different underlying causes of CVD.

Challenges in Current Models

These efforts have been hampered by the lack of proper human cardiac models.

  1. Animal Models:

    • Animal models have different physiology and gene expression from the human situation.
  2. In Vitro Models:

    • Flat cell culture in vitro models are not capable of producing pumping motion, which is the main function of the heart.

Regulatory Concerns

Furthermore, pesticide toxicity and risk for human health are controlled at a European level through a well-developed regulatory network. However, cardiotoxicity is not described as a separate hazard class, while it can have long-term cardiovascular complications.

Proposed Solution

Here we propose to make better predictive in vitro cardiac models by creating:

  1. Vascularized Beating Mini-Heart:

    • A mini-heart that mimics the human cardiac function.
  2. Self-Propulsion Swimming Bio-Robot:

    • A bio-robot made by assembling human cardiac cells into 3D tissue structures using sacrificial molding and high-resolution 3D bio-printing.

Benefits of the Project

The mini-heart and the bio-robot will enable the scientific community to have:

  • A more realistic human cardiac model in vitro.
  • A proper tool to assess the presence of cardiotoxicants in the environment.

Collaborative Effort

This work will be done in a consortium of four parties with the necessary expertise, including:

  • Heart development
  • Human pluripotent stem cells
  • 3D bioprinting
  • Tissue engineering
  • Biosensing

Together, we aim to bring these engineered living tissues to reality.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 4.475.946
Totale projectbegroting€ 4.475.946

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • UNIVERSITEIT TWENTEpenvoerder
  • NANOSCALE SYSTEMS, NANOSS GMBH
  • RIVER BIOMEDICS B.V.
  • UNIVERSIDAD DE MALAGA
  • METATISSUE - BIOSOLUTIONS, LDA

Land(en)

NetherlandsGermanySpainPortugal

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"

The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.

€ 2.996.550
EIC Pathfinder

Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.

The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.

€ 2.744.300
EIC Pathfinder

Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures

Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.

€ 2.552.277
EIC Pathfinder

Emerging technologies for crystal-based gamma-ray light sources

TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.

€ 2.643.187

Vergelijkbare projecten uit andere regelingen

ERC STG

Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs

G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.

€ 1.497.351
ERC STG

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.

€ 1.496.395
ERC COG

3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput

HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.

€ 2.969.219
ERC STG

Surgical optogenetic bioprinting of engineered cardiac muscle

LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.

€ 1.499.705